Ketoconazole enantiomer in humans
US9198906B2 · kind B2 · utility
0Cited by
11References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 2, 2007 |
| Grant date | Dec 1, 2015 |
| Priority date | — |
| Expiry date | Dec 29, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Treatment of patients with the 2S,4R ketoconazole enantiomer or its pharmaceutically acceptable salts, hydrates, and solvates is useful for reducing systemic inflammation and cholesterol levels and improving glycemic control.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.